Search results
Author(s):
Sophie Mavrogeni
,
George Markousis-Mavrogenis
,
Genovefa Kolovou
Added:
3 years ago
Rheumatoid arthritis, the spondyloarthropathies, systemic lupus erythematosus, systemic vasculitides, inflammatory myopathies, systemic sclerosis and mixed connective tissue disease are autoimmune rheumatic diseases (ARDs) with high incidence of cardiovascular disease (CVD).1 CVD is usually underestimated in patients with rheumatic diseases, because the main focus of rheumatologists is the signs…
View more
Adrian Pick
Job title: Cardiothoracic Surgeon
Author
Author(s):
Daniel X Augustine
,
Tracey Keteepe-Arachi
,
Aneil Malhotra
Added:
3 years ago
A Review of Sleep Apnoea and its Treatment in Cardiovascular Disease - An important Intervention in…
Author(s):
Holger Woehrle
,
Jochen Müller-Ehmsen
,
Erland Erdmann
Added:
3 years ago
Article
Author(s):
Kazeen Abdullah
,
Anand Rohatgi
Added:
3 years ago
Statins are currently the most efficacious and widely prescribed lipid-lowering medications.1 Numerous randomised controlled trials across a spectrum of baseline atherosclerotic cardiovascular disease (ASCVD) risk show that a 1.0 mmol/L (~40 mg/dL) reduction in low-density lipoprotein cholesterol (LDL-C) with statin therapy is associated with an overall 21 % reduction in major vascular events and…
View more
Author(s):
Kenneth McDonald
,
Ulf Dahlström
Added:
3 years ago
Despite recent advances in therapy, heart failure (HF) remains a major cardiovascular epidemic worldwide. The increasing prevalence of the syndrome demands further improvement in practice and management to curb the economic and morbidity burden.
Current Dilemmas in Heart Failure Diagnosis and Care
Heart failure is a condition characterised by non-specific symptoms and unremarkable physical…
View more
Author(s):
Harriette Van Spall
,
John Spertus
Added:
2 years ago
Late-breaker host Dr Harriette Van Spall (McMaster University, CA) invites PI, Dr John Spertus to discuss the innovative CHIEF-HF clinical trial.
The aim of this study was to determine the superiority of the effectiveness of canagliflozin versus placebo in participants with symptomatic heart failure (HF) in improving the overall Kansas City Cardiomyopathy Questionnaire (KCCQ) Total Symptom Score …
View more
Author(s):
Angela Maas
Added:
3 years ago
Over the past 40 years impressive progress has been made in treating focal, obstructive coronary artery disease (CAD) using percutaneous coronary interventions (PCI) and the most sophisticated surgical bypass techniques. Although women have profited to a great extent from these advancements, sex and gender differences in ischemic heart disease (IHD) are still under-recognised and even ignored…
View more
Author(s):
Otto A Smiseth
,
Anders Opdahl
,
Espen Boe
,
et al
Added:
3 years ago
Abstract
Heart failure with preserved left ventricular ejection fraction (HF-PEF), sometimes named diastolic heart failure, is a common condition most frequently seen in the elderly and is associated with arterial hypertension and left ventricular (LV) hypertrophy. Symptoms are attributed to a stiff left ventricle with compensatory elevation of filling pressure and reduced ability to increase…
View more
Author(s):
Gavino Casu
,
Pierluigi Merella
Added:
3 years ago
Heart failure (HF) is a syndrome defined by the failure of the heart to deliver oxygen at a rate commensurate with the requirements of the metabolising tissues, despite normal filling pressures (or only at the expense of increased filling pressures),1 secondary to an abnormality of the cardiac structure or function.
HF is the most common cause of hospitalisation in patients over the age of 65.2…
View more